American Thyroid Association® (ATA) is pleased to highlight our past exhibit partners. ATA’s THYROID EXPO offers an exhibit experience conducive for interactions and access to top experts in the field of thyroidology in a collegial setting. Our exhibit partnerships page allows exhibitor visibility and recognition throughout the year. Each year the page is updated with our current annual meeting exhibit and Corporate Leadership Council partners. We thank our partners for their support and look forward to our next opportunity to meet again in-person.
2021 ATA exhibit opportunities will be posted here by mid-to-late October 2020. Please revisit this page for details and updates as available.
NOTE: The ATA has external financial and business relationships with partners in the pharmaceutical and medical industry, which are important for its mission. In order to make these relationships transparent to its members and general public, the ATA makes available the ATA Funding Sources and Utilization Disclosure, which is updated annually. ATA does not endorse any company, program or service provided by our partners. This information is provided for informational purposes and does not necessarily reflect the viewpoints of the ATA.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
Acella Pharmaceuticals, LLC is a specialty pharmaceutical company committed to innovating the healthcare field by bringing quality and affordable products to our customers and patients. Our diverse portfolio of therapeutic products helps patients with a variety of healthcare needs. From patients with hypothyroidism, acne, eczema, cystic acne, UTIs, low iron, IBS, nutritional deficiencies, arthritis, coughs and colds or for expecting mothers in need of prenatal care, our team of experts work hard to deliver on products that help patients make their life a little better!
American Association of Clinical Endocrinologists (AACE)
AACE, established in 1991, is a professional medical community of clinical endocrinologists and physicians that treat endocrine disorders. AACE is committed to enhancing its members' ability to provide the highest quality of care. As the country's largest professional organization of clinical endocrinologists, AACE has more than 6,600 members in 97 countries, who are devoted to providing care for patients with endocrine disorders. Please visit the AACE Membership Booth for applications, our clinical guidelines, and all the latest information and resources for physicians and your patients.
AmCad BioMed Corporation
AmCad BioMed Corporation is dedicated to developing innovative Computer-Assisted Detection (CAD). Our patented algorithms provide medical professionals detailed quantification and visualization of sonographic characteristics, bolstering clinicians' expertise with AI-driven technology. AmCAD-UT® is WORLD'S FIRST clinically proven and FDA/CE certificated ultrasound CAD for Thyroid Cancer detection gives physicians the tools necessary to process ultrasound images for sonographic characteristics, which helps them make more confident diagnostic decisions.
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals (NYSE: AMRX) develops, manufactures and distributes generic, brand and biosimilar products. Amneal's growing portfolio of branded pharmaceuticals is focused on central nervous system disorders, endocrinology and parasitic infections. For more information, visit amneal.com.
Asia Oceania Thyroid Association & Chinese Society of Endocrinology
The 16th International Thyroid Congress
Barely 5 years since its establishment in 1975, AOTA organized the 8th ITC in Sydney, Australia (February 3-8, 1980). AOTA hosted the 12th ITC in Kyoto, Japan (October 22-27, 2000). For the 3rd time, AOTA will host the 16th ITC (September 8-13, 2020) in Xi’an, China, under the auspices of the Chinese Society of Endocrinology. Xi’an is a historical and cultural city regarded as one of the greatest cities of the ancient world and the cradle of Chinese civilization. The venue shall be the Qujiang International Conference and Exhibition Center which is the largest well-equipped conference center in northwest China.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
CBLPath, a Sonic Healthcare Company
ThyroSeq is an innovative test for thyroid nodules and cancer that utilizes next-generation sequencing technology and a proprietary genomic classifier to analyze 5 classes of alterations in DNA and RNA collected from a thyroid nodule, with reported results empowering physicians to individualize patient management. With rigorous validation and over 10 years of continuous refinement, ThyroSeq incorporates major scientific discoveries and technological advances to provide the most accurate diagnosis of benign or malignant disease in thyroid nodules. ThyroSeq is offered through CBLPath, a Sonic Healthcare Company. Sonic Healthcare USA is a subsidiary of Sonic Healthcare Limited, one of the world's largest medical diagnostic companies providing laboratory services.
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, manufacturing and marketing capabilities. To learn more about Eisai Inc., please visit us at www.eisai.com/US.
Endocrine Education, Inc.
ENDOCRINE EDUCATION, INC is a not-for-profit Massachusetts corporation owning and publishing WWW.THYROIDMANAGER.ORG. Our website-web-book- is a million word on-line textbook written by MDs and for MDs covering all of thyroid disease and thyroid pathophysiology. It is comprehensive, authoritative, constantly updated, and FREE, and receives about 50,000 hits by +/-2000 readers every day. Thyroidmanager is complemented by a second on-line comprehensive web –book, WWW.ENDOTEXT.ORG, covering all of Endocrinology, which receives nearly 4,000 hits by 1000 readers from around the world each day.
The Endocrine Society is the largest global community of endocrinology professionals dedicated to accelerating scientific breakthroughs and improving health worldwide. We envision a world in which advances in endocrine science, education, and care promote optimal health and well-being. We are unique in that our members are not only on the frontier of breakthrough research discoveries, but they also apply this knowledge in the treatment of patients with hundreds of debilitating hormone-related diseases and conditions, such as diabetes, obesity, osteoporosis, thyroid disorders, and infertility.
Esaote North America
Esaote North America, Indianapolis, part of the Esaote Group, a global leader in research, production and marketing diagnostic medical equipment. Among the largest manufacturers of ultrasound systems worldwide, Esaote prides itself in achieving superior price and performance. Come learn about the NEW MyLab X5, NEW MyLabX7, NEW MyLab Sigma and NEW MyLab Omega featuring advanced image quality with the highest level of performance, up to a 22mhz probe, extended connectivity, and a full screen mode capability. Visit us at www.esaoteusa.com.
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
Fluoptics Imaging Inc.
Fluoptics develops innovative fluorescence imaging solutions for real time guided surgery. The goal of Fluorescence imaging is to provide surgeons with real-time information on the location of fluorescent signal during surgery. This complementary tool secures procedures and improves patient's outcome. It makes surgeons' work easier, and by improving the efficiency of their procedures, reduces complication costs. The main product of Fluoptics is the Fluobeam®, which can be used for identifying parathyroid glands by autofluorescence and for parathyroid glands perfusion assessment. The Fluobeam® is fully controlled by the surgeon from the optical head, handled over the surgical field. More information: www.fluoptics.com
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Graves' Disease & Thyroid Foundation
The Graves' Disease & Thyroid Foundation provides evidence-based educational and support services for patients living with Graves' disease, thyroid eye disease, Hashimoto's thyroiditis, and other thyroid-related disorders. Our services are provided via phone, U.S. mail, e-mail, online bulletin boards, social media, informational online materials, local support groups, and national conferences.
Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.
IBSA Pharma Inc.
IBSA is a world leader in the treatment of thyroid disease and the developer, manufacturer and distributor of the first and only liquid levothyroxine formulation for the treatment of hypothyroidism, available in soft gel capsules and marketed as Tirosint®. For full prescribing information visit
IBSA Pharma Inc. is the U.S. Pharmaceutical subsidiary of IBSA Group, a global pharmaceutical company based in Lugano, Switzerland. IBSA is present in 9 major therapeutic areas worldwide, with a specific endocrinology focus in the United States. For more information please visit http://www.ibsagroup.com/ibsa-group/ibsa-usa.html
Interpace Diagnostics is a provider of molecular testing for numerous types of cancer including Thyroid cancer. The Company offers a next generation sequencing based mutational panel, ThyGeNEXT™, and ThyraMIR®, it’s miRNA Classifier for indeterminate thyroid nodules. ThyGeNEXT and ThyraMIR performed together represents the only combination product that has the ability to both rule in and rule out cancer. Emerging data is providing additional evidence of the clinical validity and utility of this unique test combination. Both ThyGeNEXT and ThyraMIR are covered by Medicare and most commercial payers.
Karger Publishers is presenting the brand new Graves’ Orbitopathy: A Multidisciplinary Approach – Questions and Answers, 3rd, revised and expanded edition. Free samples of European Thyroid Journal, an international journal for basic, translational and clinical thyroidology will be available. Other journals on display: Hormone Research in Paediatrics and Neuroendocrinology. The book series Endocrine Development, Frontiers in Diabetes, and Frontiers in Hormone Research will also be on display.
LID Life Community
LID Life Community (LLC) is a 501c3 non-profit organization. This organization helps guide individuals through the low iodine diet to prepare for radioactive iodine treatments and the whole body scan. Our website is filled with information about the type of salt used in products by multiple brands manufactured in several countries, photos of lid safe foods, recipes, and the supporting scientific literature. In addition, we provide online peer to peer support (https://www.facebook.com/groups/LowIodineDiet/) that helps individuals to have a less stressful experience during this phase of their treatment.
Light of Life Foundation
The Mission of the Light of Life Foundation (a 501(c)(3) non-profit organization) is to improve the quality of life of thyroid cancer patients through continual education of the lay public and the medical community, and by promoting research and development to improve thyroid cancer care.
Loxo Oncology, a wholly owned subsidiary of Eli Lilly and Company is a biopharmaceutical company focused on the development and commercialization of highly-selective medicines for patients with genomically defined cancers. Our pipeline is focused on treatments aimed at cancers caused by oncogenic drivers, which the tumor depends on for growth and survival. Loxo Oncology develops purpose-built medicines designed to selectively and potently inhibit these oncogenic drivers. We believe that this approach, combined with the use of tumor genomic testing to identify appropriate patients, will allow us to develop medicines that deliver on the promise of precision medicine.
Mary Ann Liebert, Inc.
Thyroid is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal is the exclusive source for the authoritative and updated American Thyroid Association (ATA) Guidelines for Managing Thyroid Disease. The program also includes comprehensive coverage of thyroid-related care and research with Clinical Thyroidology® and VideoEndocrinology™. This authoritative journal program delivers in-depth coverage on topics from clinical application and primary care, to the latest advances in diagnostic imaging and surgical techniques and technologies, designed to optimize patient care and outcomes.
Medtronic Surgical Technologies
Patients are at the center of everything we do —and we believe medical technology can play an even greater role in improving people’s lives. Join us in our commitment to take healthcare Further, Together. Be inspired at medtronic.com.
Medullary Thyroid Carcinoma (MTC) Registry Consortium/UBC
UBC leads the market in providing integrated, comprehensive clinical, safety, and patient services. Our experts are committed to working in unison with pharmaceutical and biotech organizations to effectively navigate the product lifecycle and make medicine and medical products safer and more accessible. By powering unsurpassed expertise and experience with proprietary software, UBC stands out in the generation of real-world evidence of product safety, value, and effectiveness.
Neurovision Medical Products
Neurovision Medical Products develops and markets intraoperative monitoring technologies for the identification and preservation of motor nerves. Founded in 1973 on the principles of surgery and electrical engineering, we continue to pioneer intraoperative nerve monitoring technologies. Our mission is to provide leading-edge neuromonitoring surgical tools that empower clinicians to improve patient outcomes. Neurovision Medical Products is located in Ventura, California, USA.
Praxis Medical Devices
The CytoCore is a revolutionary device for Fine Needle Biopsy that uses a motorized rotary mechanism to shear off cells during FNA. Come by booth 208 to see the cellular yields you could be getting in one pass using the CytoCore!
Provell Pharmaceuticals, LLC
Created in 2005, Provell Pharmaceuticals LLC specializes in the Pharmaceutical Marketing and Distribution of innovative products. Through our global partnerships, we bring innovation, without compromising quality. Our goal is to improve patient outcomes by offering chronic medications in distinctive packaging to help patients achieve better adherence and overall health.
Public Health Foundation of India
PHFI is a public private initiative that has collaboratively evolved through consultations with multiple constituencies including Indian and international academia, state and central governments, multi & bi-lateral agencies and civil society groups. PHFI is a response to redress the limited institutional capacity in India for strengthening training, research and policy development in the area of Public Health. Structured as an independent foundation, PHFI adopts a broad, integrative approach to public health, tailoring its endeavors to Indian conditions and bearing relevance to countries facing similar challenges and concerns. PHFI focuses on broad dimensions of public health that encompass promotive, preventive and therapeutic services, many of which are frequently lost sight of in policy planning as well as in popular understanding. Training Division at PHFI is implementing various skill programs for Medical Officers on the chronic diseases like diabetes, gestational diabetes, thyroid disorders, cardio diabetes and diabetic retinopathy which are aimed to enhance their knowledge, skills and core competencies.
From cell culture to immunoassays, fluorescent-detected immunoassays and molecular systems, Quidel has a multitude of solutions to address the needs of physicians and laboratorians. Quidel is a leading manufacturer of diagnostic healthcare solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. The San Diego-based manufacturer continues to meet and anticipate a wide spectrum of needs with an eye towards higher quality care for all. With a commitment to providing tools that help physicians practice antibiotic stewardship, Quidel’s innovative tools deliver accurate, fast, easy to
As a manufacturer, RF Medical is dedicated to popularizing radiofrequency ablation treatments since 2003. Our extensive product range spans from tumor ablation such as liver tumor and thyroid nodule ablation to even varicose vein treatments. Our sophisticated technology has allowed us to spread our business to more than 50 countries and our proven quality has granted us a strong reputation on the market. As always, RF Medical strives with all its capabilities to create a healthier world by continuous investment in research and development.
Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.
STARmed/Taewoong Medical USA
TaeWoong Medical is the exclusive distributor of STARmed that delivers RFA (Radio Frequency Ablation) in the treatment of superficial lesions in critical areas.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
ThyCa: Thyroid Cancer Survivors’ Association, Inc.
ThyCa: Thyroid Cancer Survivors’ Association, Inc., an international nonprofit organization advised by thyroid cancer specialists, educates and supports patients and families through its award-winning website, support groups, person-to-person support, free newsletter, downloadable handbooks and low-iodine cookbook, and materials in 10 languages. ThyCa sponsors webinars, seminars, workshops, and an annual international 3-day conference, as well as Thyroid Cancer Awareness Month, year-round awareness programs for early detection, and thyroid cancer research funds and research grants.
Thyroid Cancer Alliance
The Thyroid Cancer Alliance is an international network of national thyroid cancer patient support organisations and/or thyroid patient support groups, dedicated to working together towards providing support, information and encouragement to patients and their families. Its activities include promoting education and awareness of thyroid cancer to the general public and medical professionals; bringing together leaders of national thyroid and/or thyroid cancer support groups so that they can share information and learn from each other’s experiences; and promoting thyroid cancer awareness all over the world through participation in thyroid cancer awareness month (September). It also participates in umbrella organisations for cancer patient advocacy such as EURORDIS, Workgroup of European Cancer Advocacy Networks (WECAN), and the European Cancer Patient Coalition (ECPC). The TCA will be displaying the latest editions of its patient materials on advanced thyroid cancer, in English and Spanish at the ATA in Washington DC.
Thyroid Cancer Canada
Established as charitable organization in 2002, Thyroid Cancer Canada (TCC) is mandated to provide information and support to patients meeting the challenges of thyroid cancer. With the benefit of a Medical Advisory Panel, TCC provides authored printed matter such as A Patient’s Guide to Thyroid Cancer and the Low Iodine Diet. Additionally, support is provided via patients’ forums, detailed website, Welcome Package, telephone & email, special events, moderated patients’ online forum, and social media portals. TCC has participated in and co-authored various studies in peer-reviewed journals.
Thyroid Federation International
Thyroid Federation International (TFI) is a nonprofit organization made up of member organizations from around the globe. TFI encompasses the vision of a world thyroid organization to deal with the problems of thyroid disease on a global perspective. The objectives of TFI include a) encourage and assist the formation of patient oriented thyroid organizations b) work closely with the medical professions to promote awareness and understanding of thyroid disorders and their complications c) provide, through member organizations, information and moral support to those affected by thyroid disorders d) promote education and research related to thyroid disorders.
The #TruthAboutTC campaign is a partnership between the Thyroid Cancer Survivors’ Association, Light of Life Foundation, and Eisai Inc. that aims to help change perceptions of thyroid cancer and provide support to those affected by this serious disease. For more information please visit https://truthabouttc.com.
Veracyte is a leading genomic diagnostics company that is providing trustworthy and actionable answers that fundamentally improve patient care when current diagnostic tests are uncertain. Veracyte’s Afirma solution provides a comprehensive solution for physicians evaluating patients with potentially cancerous thyroid nodules. The next-generation Afirma Genomic Sequencing Classifier (GSC) maintains a high sensitivity of 91%, an increased specificity of 68% and a 96% negative predictive value. Adding the new Xpression Atlas (XA) to Afirma GSC provides additional genomic information to risk stratify your patients. XA sequences 511 genes to detect 761 variants and 130 fusion pairs. Learn more at www.afirma.com
Yale Pathology Labs
Yale Pathology Labs is a comprehensive anatomic pathology service with the internationally recognized teaching and research expertise of Yale University School of Medicine. When you choose to use Yale Pathology Labs you will find an exceptional medical community pooling it’s technical resources and it’s vast array of human talent to resolve the diagnostic question at hand.
UBC: An Express Scripts Company
UBC unites unsurpassed experience in generating real-world evidence of global product safety, value, and effectiveness, with the strength of its parent company, Express Scripts, one of the nation’s largest healthcare companies. UBC leads the market in providing integrated, comprehensive periapproval, safety, and commercialization services.